Skip to content
Newsletter-Size Image (7)

We Are Currently Accepting Dogs in a Clinical Study for B-Cell Lymphoma.

Check this info page or contact us through the form at the bottom of the page to learn about how to receive study treatment.

Study Purpose

Lymphoma is the most common hematological cancer in dogs and in humans. For dogs, standard treatment for B-cell Lymphoma can significantly extend their survival, however, some dogs do not benefit, and cost can be significant. We are currently accepting dogs in a clinical trial to investigate a new treatment for canine B-cell lymphoma at no cost to you.

This study will evaluate the safety and biologic activity of this newly proposed treatment in dogs who are currently diagnosed with B-cell Lymphoma.

 

Access to a potential new treatment for b-cell lymphoma
The opportunity to be part of medical innovations for veterinary science
Eligible for compensation

What Will Happen in The Study?

There will be:

  • Physical examinations
  • Lab work
  • Study treatment
  • 4 visits over the course of approximately 4 weeks

Is My Pet Eligible to Enroll?

*Requirements for Eligibility to Participate Include (but aren’t limited to):

  • Dog has been diagnosed with B-cell lymphoma.
  • Dog is over 12 months of age.
  • Dog has naïve or relapsed B-cell lymphoma, stage a.
  • Dog has adequate organ function.
  • Dog cannot have lymphoma considered substage b.
  • Dog cannot be pregnant or lactating, or intended for breeding during the study
  • Dog must meet mandatory washout period

*Please talk to the study veterinarian for more information.

Compensation

The study covers all related costs, including:

  • Physical exams
  • Lab work
  • Study Treatment